Stay updated on Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    No substantive changes to the study details; the screenshots show only minor layout/formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T23:04:57.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    - Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T13:49:26.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Page updated from v3.0.2 to v3.1.0; a specific term (Melanoma, Cutaneous Malignant) was removed. If core content and essentials are unchanged, this is a minor revision update with terminology pruning.
    Difference
    0.1%
    Check dated 2025-09-29T09:45:07.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T23:39:09.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T20:17:52.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical terms related to treatments for skin and connective tissue diseases. Notably, the revision number has been updated to v3.0.0.
    Difference
    2%
    Check dated 2025-08-31T12:57:24.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.